Molecular Imaging World Summit 2019
MI—the gateway to precision medicine

Thursday, May 16-Saturday, May 18
Lausanne, Switzerland
Molecular Imaging World Summit 2019
Molecular Imaging World Summit 2019
 
Download summit guide

Overview

Hosted by Siemens Healthineers, the Molecular Imaging World Summit offers Symbia™ SPECT and Biograph™ PET users the chance to discuss clinical successes, new directions, and key research developments. The program will kick off Thursday evening with a casual welcome reception, followed by two days of scientific presentations and panel discussions.

For more information, please contact us at MISummit2019@siemens-healthineers.com.

Venue

The Molecular Imaging World Summit 2019 will take place in Lausanne, Switzerland. Situated on the shores of Lake Geneva, Lausanne is approximately one hour from Geneva.

Mövenpick Hotel Lausanne
Avenue de Rhodanie 4
1007 Lausanne, Switzerland

Program Overview

Featuring more than 25 talks over two days, the MI World Summit program will highlight the impact of molecular imaging on modern patient care and its role as the gateway to precision medicine.

Day 1
Laying the foundation with quantification

  • The origins of PET/CT and its quantitative foundation
  • Quantification for RT planning
  • SUV harmonization and beyond
  • Defining thresholds for quantitative SPECT/CT imaging
  • Parametric PET imaging

Early diagnosis and planning

  • First experiences with Biograph Vision PET/CT
  • Perspectives on utilizing SPECT/CT in orthopedics
  • Quantitative SPECT/CT applications in oncology, neurology, and cardiology
  • Current trends in neurology and the growing demands for imaging
  • Early detection and treatment of cardiovascular disease: the future and what’s needed
  • Measuring total tumor burden as a tool for therapy planning and response assessment

Day 2
Treatment management

  • Progressing theranostics through drug development
  • Quantitative SPECT/CT imaging for response assessment and treatment tailoring
  • Molecular imaging for immunotherapy
  • Therapy advancements for recurrent prostate cancer

Progressing molecular imaging

  • Enabling opportunity with dynamic PET/CT imaging
  • PET/CT gating and the future of motion management
  • Molecular imaging’s role in China’s future healthcare
  • Considerations for quantitative cardiac SPECT/CT and coronary CTA
  • Progressing MI through novel tracer development
  • Artificial intelligence in MI: latest innovations